Prudential Financial
DNTH icon

Prudential Financial’s Dianthus Therapeutics DNTH Stock Holding History

Prudential Financial’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
+18,126
New +$1.05M ﹤0.01% 1435
2020
Q4 		– Sell
-1,176
Closed -$128K – 2460
2020
Q3 		$128K Buy
+1,176
New +$139K ﹤0.01% 2348

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Prudential Financial's DNTH Position: Q1 2026 in Review

Prudential Financial opened a new position in Dianthus Therapeutics (DNTH) in Q1 2026: 18,126 shares worth $1.52M. The stake represents ﹤0.01% of the portfolio and ranks #1435 among its holdings. This is a return to the name: Prudential Financial previously reported a position in DNTH as recently as Q3 2020.

Prudential Financial first reported a position in DNTH in Q3 2020 and has held it in 2 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Prudential Financial held 18,126 shares of Dianthus Therapeutics worth $1.52M as of Q1 2026.
  • Dianthus Therapeutics was a new Prudential Financial position in Q1 2026.
  • Dianthus Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1435 holding.
  • Prudential Financial first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 2 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.